Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treatment of coronary heart disease of type of stagnation of cardiac blood

A technology for blood stasis and coronary heart disease, which is applied in the field of pharmacy, can solve problems such as damage to the digestive system, and achieve high safety, no toxic side effects, and long-lasting effects

Inactive Publication Date: 2016-04-27
济南思拓新源医药科技有限公司
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Patients with coronary heart disease need to insist on taking long-term drugs such as nitrates (such as nitroglycerin, etc.), aspirin or Danshen dripping pills to relieve the condition of coronary heart disease and avoid various acute attacks, but these drugs need to be taken every day, and long-term use will have adverse effects on damage to the digestive system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1 tablet

[0040] The embodiment of the present invention provides a medicine for treating heart-blood stasis type coronary heart disease, which is made of the following raw medicinal materials in parts by weight: 17 parts by weight of Caulis chinensis, 1 part by weight of Salvia miltiorrhiza, 12 parts by weight of Zicao antler, poured 11 parts by weight of buckle grass, 15 parts by weight of pheasant feast, 6 parts by weight of pepper stem, 16 parts by weight of lemongrass, 19 parts by weight of chicken tree, 13 parts by weight of tallow, 12 parts by weight of clematis and 12 parts by weight of chrysanthemum parts by weight;

[0041] Its preparation method is:

[0042] The first step is to mix the raw materials of the traditional Chinese medicine in proportion, add ethanol with an alcohol concentration of 90% that is 2 to 4 times the mass of the mixture, heat and reflux for 2 hours, extract, and filter to obtain the first extract; The dregs are then added wit...

Embodiment 2

[0045] Embodiment 2 drop pills

[0046] The embodiment of the present invention provides a medicine for treating blood stasis type coronary heart disease, which is made of the following raw materials by weight: the medicine is made of the following raw materials by weight: 17 parts by weight , 1 part by weight of salvia miltiorrhiza, 12 parts by weight of velvet comfrey, 11 parts by weight of scalloped grass, 15 parts by weight of pheasant feast, 6 parts by weight of pepper stem, 16 parts by weight of lemongrass, 19 parts by weight of chicken tree strips, 13 parts by weight of tallow tree part, 12 parts by weight of clematis, 12 parts by weight of lotus chrysanthemum, 21 parts by weight of chicken tendon ginseng, 11 parts by weight of Radix Ophiopogon japonicus, 7 parts by weight of Divine Comedy and 15 parts by weight of Chickweed;

[0047] Its preparation method is:

[0048] (1) Weigh and mix all raw materials and medicinal materials according to parts by weight, add water ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a medicine for treatment of coronary heart disease of type of stagnation of cardiac blood, and the medicine includes the following raw medicinal ingredients: Mucuna sempervirens Hemsl, Salvia miltiorrhiza, Lac, herb of common achyranthes, Chilli stem, Potentilla fragarioides, Cymbopogon citratus, viburnum sargenti, Root of Kerr Treebine, Clematis florida Thunb. and Polygala fallax Hemsl. The beneficial effects are as follows: the medicine focus on the treatment of coronary heart disease of type of stagnation of cardiac blood on the basis of the theory of traditional Chinese medicine, and has the advantages of good clinical efficacy, long efficacy duration, high safety, no toxic side effects, and the like.

Description

technical field [0001] The invention relates to the technical field of pharmacy, in particular to a medicine for treating heart-blood stasis type coronary heart disease. Background technique [0002] Coronary heart disease is a heart disease caused by atherosclerotic lesions in the coronary arteries that cause stenosis or blockage of the vessel lumen, resulting in myocardial ischemia, hypoxia or necrosis. The clinical manifestation is chest pain. Sudden precordial pain induced by physical activity, emotional agitation, etc. is mostly episodic colic or squeezing pain, and it can also be a feeling of depression. The pain starts from the back of the sternum or the front of the heart, and radiates upward to the left shoulder, arm, and even the little finger and ring finger. It can be relieved by rest or taking nitroglycerin. The part where the chest pain radiates can also involve the neck, jaw, teeth, abdomen, etc. Chest pain can also occur in a quiet state or at night, caus...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P9/10
CPCA61K36/899A61K9/2059A61K36/00A61K36/185A61K36/21A61K36/30A61K36/35A61K36/486A61K36/537A61K36/69A61K36/716A61K36/73A61K36/74A61K36/81A61K36/87A61K36/8968A61K2236/19A61K2300/00
Inventor 贾旭升公蕾
Owner 济南思拓新源医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com